These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
370 related items for PubMed ID: 10617745
1. Maternal and infant factors predicting disease progression in human immunodeficiency virus type 1-infected infants. Women and Infants Transmission Study Group. Rich KC, Fowler MG, Mofenson LM, Abboud R, Pitt J, Diaz C, Hanson IC, Cooper E, Mendez H. Pediatrics; 2000 Jan; 105(1):e8. PubMed ID: 10617745 [Abstract] [Full Text] [Related]
2. Risk factors for perinatal transmission of human immunodeficiency virus type 1 in women treated with zidovudine. Pediatric AIDS Clinical Trials Group Study 185 Team. Mofenson LM, Lambert JS, Stiehm ER, Bethel J, Meyer WA, Whitehouse J, Moye J, Reichelderfer P, Harris DR, Fowler MG, Mathieson BJ, Nemo GJ. N Engl J Med; 1999 Aug 05; 341(6):385-93. PubMed ID: 10432323 [Abstract] [Full Text] [Related]
3. HIV-1 genotypic zidovudine drug resistance and the risk of maternal--infant transmission in the women and infants transmission study. The Women and Infants Transmission Study Group. Welles SL, Pitt J, Colgrove R, McIntosh K, Chung PH, Colson A, Lockman S, Fowler MG, Hanson C, Landesman S, Moye J, Rich KC, Zorrilla C, Japour AJ. AIDS; 2000 Feb 18; 14(3):263-71. PubMed ID: 10716502 [Abstract] [Full Text] [Related]
4. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection. Siegfried N, van der Merwe L, Brocklehurst P, Sint TT. Cochrane Database Syst Rev; 2011 Jul 06; (7):CD003510. PubMed ID: 21735394 [Abstract] [Full Text] [Related]
5. Predictors of early mortality in a cohort of human immunodeficiency virus type 1-infected african children. Obimbo EM, Mbori-Ngacha DA, Ochieng JO, Richardson BA, Otieno PA, Bosire R, Farquhar C, Overbaugh J, John-Stewart GC. Pediatr Infect Dis J; 2004 Jun 06; 23(6):536-43. PubMed ID: 15194835 [Abstract] [Full Text] [Related]
6. Disease progression in a cohort of infants with vertically acquired HIV infection observed from birth: the Women and Infants Transmission Study (WITS). Diaz C, Hanson C, Cooper ER, Read JS, Watson J, Mendez HA, Pitt J, Rich K, Smeriglio V, Lew JF. J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Jul 01; 18(3):221-8. PubMed ID: 9665498 [Abstract] [Full Text] [Related]
7. Effect of prenatal zidovudine on disease progression in perinatally HIV-1-infected infants. de Souza RS, Gómez-Marín O, Scott GB, Guasti S, O'Sullivan MJ, Oliveira RH, Mitchell CD. J Acquir Immune Defic Syndr; 2000 Jun 01; 24(2):154-61. PubMed ID: 10935691 [Abstract] [Full Text] [Related]
8. Maternal viral load, zidovudine treatment, and the risk of transmission of human immunodeficiency virus type 1 from mother to infant. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. Sperling RS, Shapiro DE, Coombs RW, Todd JA, Herman SA, McSherry GD, O'Sullivan MJ, Van Dyke RB, Jimenez E, Rouzioux C, Flynn PM, Sullivan JL. N Engl J Med; 1996 Nov 28; 335(22):1621-9. PubMed ID: 8965861 [Abstract] [Full Text] [Related]
9. Maternal and perinatal factors related to maternal-infant transmission of HIV-1 in the P2C2 HIV study: the role of EBV shedding. Pediatric Pulmonary and Cardiovascular Complications of Vertically Transmitted HIV-1 Infection (P2C2 HIV) Study Group. Pitt J, Schluchter M, Jenson H, Kovacs A, LaRussa P, McIntosh K, Boyer P, Cooper E, Goldfarb J, Hammill H, Hodes D, Peavy H, Sperling R, Tuomala R, Shearer W. J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Dec 15; 19(5):462-70. PubMed ID: 9859959 [Abstract] [Full Text] [Related]
10. Predictors of immunologic long-term nonprogression in HIV-infected children: implications for initiating therapy. Paul ME, Mao C, Charurat M, Serchuck L, Foca M, Hayani K, Handelsman EL, Diaz C, McIntosh K, Shearer WT, Women and Infants Transmission Study. J Allergy Clin Immunol; 2005 Apr 15; 115(4):848-55. PubMed ID: 15806009 [Abstract] [Full Text] [Related]
11. Morbidity and mortality among a cohort of human immunodeficiency virus type 1-infected and uninfected pregnant women and their infants from Malawi, Zambia, and Tanzania. Chilongozi D, Wang L, Brown L, Taha T, Valentine M, Emel L, Sinkala M, Kafulafula G, Noor RA, Read JS, Brown ER, Goldenberg RL, Hoffman I, HIVNET 024 Study Team. Pediatr Infect Dis J; 2008 Sep 15; 27(9):808-14. PubMed ID: 18679152 [Abstract] [Full Text] [Related]
12. Maternal levels of plasma human immunodeficiency virus type 1 RNA and the risk of perinatal transmission. Women and Infants Transmission Study Group. Garcia PM, Kalish LA, Pitt J, Minkoff H, Quinn TC, Burchett SK, Kornegay J, Jackson B, Moye J, Hanson C, Zorrilla C, Lew JF. N Engl J Med; 1999 Aug 05; 341(6):394-402. PubMed ID: 10432324 [Abstract] [Full Text] [Related]
13. Predictors and impact of losses to follow-up in an HIV-1 perinatal transmission cohort in Malawi. Ioannidis JP, Taha TE, Kumwenda N, Broadhead R, Mtimavalye L, Miotti P, Yellin F, Contopoulos-Ioannidis DG, Biggar RJ. Int J Epidemiol; 1999 Aug 05; 28(4):769-75. PubMed ID: 10480709 [Abstract] [Full Text] [Related]
14. Effect of maternal CD4+ cell count, acquired immunodeficiency syndrome, and viral load on disease progression in infants with perinatally acquired human immunodeficiency virus type 1 infection. New York City Perinatal HIV Transmission Collaborative Study Group. Lambert G, Thea DM, Pliner V, Steketee RW, Abrams EJ, Matheson P, Thomas PA, Greenberg B, Brown TM, Bamji M, Kalish ML. J Pediatr; 1997 Jun 05; 130(6):890-7. PubMed ID: 9202610 [Abstract] [Full Text] [Related]
15. Safety of late in utero exposure to zidovudine in infants born to human immunodeficiency virus-infected mothers: Bangkok. Bangkok Collaborative Perinatal HIV Transmission Study Group. Chotpitayasunondh T, Vanprapar N, Simonds RJ, Chokephaibulkit K, Waranawat N, Mock P, Stat MA, Chuachoowong R, Young N, Mastro TD, Shaffer N. Pediatrics; 2001 Jan 05; 107(1):E5. PubMed ID: 11134469 [Abstract] [Full Text] [Related]
16. Maternal viral load and rate of disease progression among vertically HIV-1-infected children: an international meta-analysis. Ioannidis JP, Tatsioni A, Abrams EJ, Bulterys M, Coombs RW, Goedert JJ, Korber BT, Mayaux MJ, Mofenson LM, Moye J, Newell ML, Shapiro DE, Teglas JP, Thompson B, Wiener J. AIDS; 2004 Jan 02; 18(1):99-108. PubMed ID: 15090835 [Abstract] [Full Text] [Related]
17. Maternal health factors and early pediatric antiretroviral therapy influence the rate of perinatal HIV-1 disease progression in children. Abrams EJ, Wiener J, Carter R, Kuhn L, Palumbo P, Nesheim S, Lee F, Vink P, Bulterys M, Perinatal AIDS Collaborative Transmission Study (PACTS) Group. AIDS; 2003 Apr 11; 17(6):867-77. PubMed ID: 12660534 [Abstract] [Full Text] [Related]
18. Identification of levels of maternal HIV-1 RNA associated with risk of perinatal transmission. Effect of maternal zidovudine treatment on viral load. Dickover RE, Garratty EM, Herman SA, Sim MS, Plaeger S, Boyer PJ, Keller M, Deveikis A, Stiehm ER, Bryson YJ. JAMA; 1996 Feb 28; 275(8):599-605. PubMed ID: 8594240 [Abstract] [Full Text] [Related]
19. Human immunodeficiency virus (HIV) type 1 antibodies in perinatal HIV-1 infection: association with human HIV-1 transmission, infection, and disease progression. For the Women and Infants Transmission Study. Pitt J, Henrard D, FitzGerald G, Mofenson L, Lew J, Hillyer G, Mendez H, Cooper E, Hanson C, Rich KC. J Infect Dis; 2000 Oct 28; 182(4):1243-6. PubMed ID: 10979926 [Abstract] [Full Text] [Related]
20. Viral load and disease progression in infants infected with human immunodeficiency virus type 1. Women and Infants Transmission Study Group. Shearer WT, Quinn TC, LaRussa P, Lew JF, Mofenson L, Almy S, Rich K, Handelsman E, Diaz C, Pagano M, Smeriglio V, Kalish LA. N Engl J Med; 1997 May 08; 336(19):1337-42. PubMed ID: 9134873 [Abstract] [Full Text] [Related] Page: [Next] [New Search]